ONTX Annual EBIT
-$20.30 M
-$671.00 K-3.42%
31 December 2023
Summary:
As of February 5, 2025, ONTX annual earnings before interest & taxes is -$20.30 million, with the most recent change of -$671.00 thousand (-3.42%) on December 31, 2023. During the last 3 years, it has risen by +$4.70 million (+18.79%).ONTX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ONTX Quarterly EBIT
-$5.21 M
-$750.00 K-16.81%
31 March 2024
Summary:
As of February 5, 2025, ONTX quarterly earnings before interest & taxes is -$5.21 million, with the most recent change of -$750.00 thousand (-16.81%) on March 31, 2024. Over the past year, it has dropped by -$750.00 thousand (-16.81%).ONTX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ONTX TTM EBIT
-$19.37 M
+$925.00 K+4.56%
31 March 2024
Summary:
As of February 5, 2025, ONTX TTM earnings before interest & taxes is -$19.37 million, with the most recent change of +$925.00 thousand (+4.56%) on March 31, 2024. Over the past year, it has increased by +$925.00 thousand (+4.56%).ONTX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ONTX EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -3.4% | -16.8% | +4.6% |
| 3 y3 years | +18.8% | -16.8% | +4.6% |
| 5 y5 years | +12.8% | -16.8% | +4.6% |
ONTX EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | +23.2% | -175.3% | +79.7% |
Onconova Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | - | -$5.21 M(+16.8%) | -$19.37 M(-4.6%) |
| Dec 2023 | -$20.30 M(+3.4%) | -$4.46 M(-12.3%) | -$20.30 M(-5.9%) |
| Sept 2023 | - | -$5.09 M(+10.4%) | -$21.57 M(-2.5%) |
| June 2023 | - | -$4.61 M(-24.9%) | -$22.12 M(+2.3%) |
| Mar 2023 | - | -$6.14 M(+7.0%) | -$21.63 M(+10.2%) |
| Dec 2022 | -$19.63 M(+19.0%) | -$5.73 M(+1.6%) | -$19.63 M(+11.2%) |
| Sept 2022 | - | -$5.64 M(+36.9%) | -$17.66 M(+10.3%) |
| June 2022 | - | -$4.12 M(-0.3%) | -$16.00 M(-3.2%) |
| Mar 2022 | - | -$4.13 M(+9.8%) | -$16.53 M(+0.2%) |
| Dec 2021 | -$16.50 M(-34.0%) | -$3.76 M(-5.7%) | -$16.50 M(-13.1%) |
| Sept 2021 | - | -$3.99 M(-14.1%) | -$18.99 M(-10.7%) |
| June 2021 | - | -$4.64 M(+13.3%) | -$21.27 M(-11.2%) |
| Mar 2021 | - | -$4.10 M(-34.5%) | -$23.97 M(-4.1%) |
| Dec 2020 | -$24.99 M(+15.2%) | -$6.25 M(-0.3%) | -$24.99 M(+2.2%) |
| Sept 2020 | - | -$6.27 M(-14.5%) | -$24.47 M(+5.0%) |
| June 2020 | - | -$7.34 M(+43.2%) | -$23.29 M(+18.9%) |
| Mar 2020 | - | -$5.13 M(-10.5%) | -$19.58 M(-9.8%) |
| Dec 2019 | -$21.70 M(-6.8%) | -$5.73 M(+12.4%) | -$21.70 M(-1.9%) |
| Sept 2019 | - | -$5.10 M(+40.3%) | -$22.12 M(-2.2%) |
| June 2019 | - | -$3.63 M(-49.8%) | -$22.61 M(-8.1%) |
| Mar 2019 | - | -$7.24 M(+17.8%) | -$24.62 M(+5.8%) |
| Dec 2018 | -$23.28 M(-9.5%) | -$6.15 M(+9.9%) | -$23.28 M(+0.1%) |
| Sept 2018 | - | -$5.59 M(-0.8%) | -$23.25 M(-4.8%) |
| June 2018 | - | -$5.64 M(-4.5%) | -$24.42 M(-1.7%) |
| Mar 2018 | - | -$5.90 M(-3.5%) | -$24.85 M(-3.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2017 | -$25.74 M(+8.6%) | -$6.12 M(-9.5%) | -$25.74 M(-1.4%) |
| Sept 2017 | - | -$6.76 M(+11.4%) | -$26.09 M(+10.3%) |
| June 2017 | - | -$6.07 M(-10.6%) | -$23.65 M(+2.9%) |
| Mar 2017 | - | -$6.79 M(+5.0%) | -$22.98 M(-3.1%) |
| Dec 2016 | -$23.70 M(-1.1%) | -$6.47 M(+49.9%) | -$23.70 M(+69.0%) |
| Sept 2016 | - | -$4.32 M(-20.1%) | -$14.02 M(-10.0%) |
| June 2016 | - | -$5.40 M(-28.2%) | -$15.59 M(-18.6%) |
| Mar 2016 | - | -$7.52 M(-334.2%) | -$19.14 M(-20.1%) |
| Dec 2015 | -$23.97 M(-62.4%) | $3.21 M(-154.6%) | -$23.97 M(-40.9%) |
| Sept 2015 | - | -$5.88 M(-34.4%) | -$40.54 M(-18.2%) |
| June 2015 | - | -$8.96 M(-27.5%) | -$49.55 M(-13.6%) |
| Mar 2015 | - | -$12.35 M(-7.6%) | -$57.36 M(-10.0%) |
| Dec 2014 | -$63.74 M(+2.6%) | -$13.36 M(-10.3%) | -$63.74 M(-1.7%) |
| Sept 2014 | - | -$14.89 M(-11.2%) | -$64.84 M(-7.4%) |
| June 2014 | - | -$16.76 M(-10.5%) | -$70.06 M(+6.4%) |
| Mar 2014 | - | -$18.73 M(+29.6%) | -$65.86 M(+6.0%) |
| Dec 2013 | -$62.12 M(+191.6%) | -$14.45 M(-28.1%) | -$62.12 M(+7.2%) |
| Sept 2013 | - | -$20.10 M(+59.9%) | -$57.92 M(+87.5%) |
| June 2013 | - | -$12.57 M(-16.1%) | -$30.90 M(+21.1%) |
| Mar 2013 | - | -$14.99 M(+46.0%) | -$25.51 M(+19.8%) |
| Dec 2012 | -$21.30 M(-18.9%) | -$10.26 M(-248.3%) | -$21.30 M(+92.9%) |
| Sept 2012 | - | $6.92 M(-196.3%) | -$11.04 M(-38.5%) |
| June 2012 | - | -$7.19 M(-33.3%) | -$17.96 M(+66.7%) |
| Mar 2012 | - | -$10.78 M | -$10.78 M |
| Dec 2011 | -$26.27 M | - | - |
FAQ
- What is Onconova Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Onconova Therapeutics?
- What is Onconova Therapeutics annual EBIT year-on-year change?
- What is Onconova Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Onconova Therapeutics?
- What is Onconova Therapeutics quarterly EBIT year-on-year change?
- What is Onconova Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Onconova Therapeutics?
- What is Onconova Therapeutics TTM EBIT year-on-year change?
What is Onconova Therapeutics annual earnings before interest & taxes?
The current annual EBIT of ONTX is -$20.30 M
What is the all time high annual EBIT for Onconova Therapeutics?
Onconova Therapeutics all-time high annual earnings before interest & taxes is -$16.48 M
What is Onconova Therapeutics annual EBIT year-on-year change?
Over the past year, ONTX annual earnings before interest & taxes has changed by -$671.00 K (-3.42%)
What is Onconova Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of ONTX is -$5.21 M
What is the all time high quarterly EBIT for Onconova Therapeutics?
Onconova Therapeutics all-time high quarterly earnings before interest & taxes is $6.92 M
What is Onconova Therapeutics quarterly EBIT year-on-year change?
Over the past year, ONTX quarterly earnings before interest & taxes has changed by -$750.00 K (-16.81%)
What is Onconova Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of ONTX is -$19.37 M
What is the all time high TTM EBIT for Onconova Therapeutics?
Onconova Therapeutics all-time high TTM earnings before interest & taxes is -$10.78 M
What is Onconova Therapeutics TTM EBIT year-on-year change?
Over the past year, ONTX TTM earnings before interest & taxes has changed by +$925.00 K (+4.56%)